Form 4: Alignment Healthcare CMO Sells Shares for Tax Obligations

Alignment Healthcare's Chief Medical Officer, Hyong Kim, sold 18,404 shares of common stock at a weighted-average price of $17.84 to cover tax withholding obligations.

Summary

• Chief Medical Officer Hyong Kim of Alignment Healthcare, Inc. (ALHC) sold 18,404 shares of common stock.
• The sale occurred on March 18, 2026, at a weighted-average price of $17.84 per share.
• The shares were sold to cover tax withholding obligations related to the vesting of restricted stock units.
• This transaction was not a discretionary trade by the reporting person.
• Following the transaction, Hyong Kim beneficially owns 367,701 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is non-discretionary and for tax purposes, which is a routine occurrence for executives receiving equity compensation, and does not signal a change in company fundamentals or management's confidence.

Future Outlook

NA

Management Comments

• Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• This transaction does not represent a discretionary trade by the reporting person.

Industry Context

StockSavvy.ai notes that routine insider sales for tax withholding purposes are common occurrences, especially with executive compensation packages that include restricted stock units. These transactions typically do not reflect a change in management's outlook on the company's future performance, unlike discretionary sales.

Comparison to Industry Standards

• Insider sales for tax obligations are standard practice across all industries for executives receiving equity compensation.
• For example, similar tax-related sales are frequently observed at companies like UnitedHealth Group (UNH) or CVS Health (CVS) when executives' restricted stock units vest.
• The reported price range of $17.40 to $18.24 for ALHC shares is specific to the company's current market valuation and not directly comparable to other companies' share prices without broader context.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a routine, non-discretionary sale for tax purposes, not indicative of a change in company outlook.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by a Chief Medical Officer to cover tax obligations upon the vesting of restricted stock units. Such transactions are common and do not typically reflect a change in the insider's view of the company's prospects or fundamental performance. Therefore, this specific filing does not provide a basis for a "buy" or "sell" recommendation, and a "hold" stance is appropriate as it does not alter the investment thesis.

Keywords

Alignment Healthcare, ALHC, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Chief Medical Officer, Hyong Kim